Analysts Set Encompass Health Co. (NYSE:EHC) Target Price at $107.11

Shares of Encompass Health Co. (NYSE:EHC) have been assigned a consensus recommendation of “Buy” from the eleven brokerages that are presently covering the company, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $107.11.

EHC has been the topic of a number of recent research reports. Truist Financial restated a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. UBS Group lifted their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. KeyCorp boosted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Barclays increased their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Royal Bank of Canada increased their price target on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th.

Hedge Funds Weigh In On Encompass Health

Several large investors have recently modified their holdings of the business. UMB Bank n.a. boosted its holdings in Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after buying an additional 252 shares during the period. V Square Quantitative Management LLC boosted its holdings in shares of Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the period. Avior Wealth Management LLC purchased a new position in shares of Encompass Health in the third quarter valued at $40,000. Benjamin F. Edwards & Company Inc. raised its stake in shares of Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after purchasing an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Encompass Health during the 2nd quarter worth about $58,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $91.18 on Tuesday. The stock’s 50 day moving average is $98.90 and its 200-day moving average is $93.47. Encompass Health has a twelve month low of $66.36 and a twelve month high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $9.19 billion, a price-to-earnings ratio of 22.02, a PEG ratio of 1.30 and a beta of 0.86.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same period last year, the company earned $0.86 earnings per share. The business’s revenue was up 11.9% on a year-over-year basis. Sell-side analysts forecast that Encompass Health will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.75%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is currently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.